Mycobacterium tuberculosis infection in patients with systemic rheumatic diseases. A case-series

Clinical and Experimental Rheumatology

Volumn 17, Issue 3, 1999, Pages 289-296

  Hernandez Cruz B ^a   Sifuentes Osornio, J ^a   Ponce De Leon Rosales S ^a   Ponce De Leon Garduno A ^a   Diaz Jouanen E ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Developing countries; Systemic lupus erythematosus; Systemic rheumatic diseases; Tuberculosis

Indexed keywords

AZATHIOPRINE; CHLOROQUINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; ETHAMBUTOL; IMMUNOSUPPRESSIVE AGENT; ISONIAZID; METHOTREXATE; PREDNISONE; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COUGHING; DEVELOPING COUNTRY; DIAPHORESIS; DISEASE ASSOCIATION; DYSPNEA; FEMALE; FEVER; HUMAN; LUNG TUBERCULOSIS; MALE; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RELAPSE; RHEUMATIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX RADIOGRAPHY; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MEXICO; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RETROSPECTIVE STUDIES; RHEUMATIC DISEASES; TUBERCULOSIS;

EID: 0344759102     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. SMITH PG, MOSS AR: Epidemiology of tuberculosis. In BLOOM BR: Tuberculosis: Pathogenesis, Protection and Control American Society for Microbiology, Washington D.C. 1994: 47-59.
2. SPENCE DPS, HOTCHIKISS J, DAVIES PDO: Tuberculosis and poverty. BMJ 1993; 307: 759-61.
3. FITZGERALD JM, GRZYBOWSKY S, ALLEN EA: The impact of human immunodeficiency virus infection on tuberculosis and its control. Chest 1991; 100: 191-200.
4. REVEILLE J, BARTOLUCCI A, ALARCÓN G: Prognosis in systemic lupus erythematosus. Arthritis Rheum 1990; 33: 37-48.
5. SEGAL B, SNELLER M: Infectious complications of immunosuppressive therapy in patients with rheumatic diseases. Rheum Dis Clin North Am 1997; 23: 219-37.
6. MILLAR JW, HORNE NW: Tuberculosis in immunosuppressed patients. Lancet 1979; i: 1176-8.
7. NAVARRA V, ARROYO C, TORRALBA T: Tuberculosis among Filipino patients with systemic lupus erythematosus. Semin Arthritis Rheum 1996: 26; 628-34.
8. GARCÍA-GARCÍA ML, VALDESPINO-GÓMEZ JL, GARCÍA-SANCHO MC, SALCEDO-ALVAREZ RA: Epidemiología de VIH/SIDA y tuberculosis, in SADA DÍAZ E and SIFUENTES OSORNIO J (Eds.): Tuberculosis. Interamericana-MacGraw Hill, México, 1995; pp. 809-22.
9. HERNÁNDEZ-CRUZ B, PONCE-DE-LEÓN-ROSALES S, SIFUENTES-OSORNIO J, PONCE-DE-LEÓN-GARDUÑO A, DÍAZ-JOUANEN E: Tuberculosis prophylaxis in patients with steroid treatment and systemic rheumatic diseases. A case-control study. Clin Exp Rheumatol 1999; 17: 81-7.
10. KIM HA, YOO CD, BACK HJ et al.: Mycobacterium tuberculosis infection in a corticosteroid-treated rheumatic disease patient population. Clin Exp Rheumatol 1998; 16: 9-13.
11. FENG PH, TAN TH: Tuberculosis in patients with systemic lupus erythematosus. Ann Rheum Dis 1982; 41: 11-14.
12. KNAPP T: A methodological critique of the ideal weight concept. JAMA 1983; 250: 506-10.
13. TAN EM, COHEN AS, FRIES JF et al.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
14. ARNETT FC, EDWORTHY SM, BLOCK DA, et al.: The American Rheumatism Association criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1987; 30: 517-24.
15. LEAVITT RY, FAUCI AS, BLOCK DA, et al.: The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 33: 1101-7.
16. MILLS JA, MICHEL BA, BLOCK DA et al.: The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum 1990; 33: 1114-21.
17. SUBCOMMITTEE FOR SCLERODERMA CRITERIA OF THE ARA DIAGNOSTIC AND THERAPEUTIC CRITERIA COMMITTEE: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
18. BOHAN A, PETER JB: Polymyositis and dermatomyositis. New Engl J Med 1975; 292: 344-7 & 403-7.
19. ALARCÓN-SEGOVIA D, VILLARREAL M: Classification and diagnostic criteria for mixed connective tissue disease. In KASUKAWA R and SHARP GC (Eds.): Mixed Connective Tissue Disease. Elsevier Science Publishers, Amsterdam 1987: 33-40.
20. DES PREZ RM, HEIM CR: Mycobacterium tuberculosis. In MANDELL GL, DOUGLAS RG and BENNETT JE: Principles and Practice of Infectious Diseases, 3rd ed. Churchill Livingstone, New York 1990: 1877-906.
21. ROBERTS GL, KONEMAN EW, KIMM YK: Mycobacterium. In BALOWS A, HAUSLER WJ JR, HERRMANN KL, ISENBERG HD and SHADOMY HJ (Eds.): Manual of Clinical Microbiology, 5th ed. American Society for Microbiology, Washington 1991: 304-39.
22. HAWKINS JE, WALLACE RJ, BROWN BA: Antimicrobial susceptibility tests: Mycobacteria. In BALOWS A, HAUSLER WJ, HERRMANN KL, ISENBERG HD, and SHADOMY HJ (Eds.): Manual of Clinical Microbiology, 5th ed. American Society for Microbiology, Washington 1991: 1138-52.
23. GULD J, BENTZON MW, BLEIKER MA, GRIEP WA, MAGNUSSON M, WAALER H: Standardization of a new batch of purified tuberculin (PPD) intended for international use. Bull WHO 1958; 19: 845-83.
24. GLASSROTH J, ROBINS AG, SNIDER DE JR: Tuberculosis in the 1980's. New Engl J Med 1980; 302: 1441-50.
25. KOPANOFF D, SNIDER D, CARAAS G: Isoniazid related hepatitis. Am Rev Resp Dis 1978; 117: 991-1001.
26. HOLDEN M, BUBIN MR, DIAMOND PH: Frequency of negative intermediate strength tuberculin sensitivity in patients with active tuberculosis. N Engl J Med 1971; 285: 1506-9.
27. WIER J, SCHLESS J: The tuberculin reaction in 530 patients admitted to the Tuberculosis Service, Fitzsimons Army Hospital. Am Rev Resp Dis 1959; 80: 569-74.
28. MOLINA-GAMBOA JD, PONCE-DE-LEÓN-ROSALES S, RIVERA-MORALES I et al.: Evaluation of the sensitivity of RT-23 purified protein derivative for determining tuberculin reactivity in a group of health care workers. Clin Infect Dis 1994; 19: 784-6.